Bruker Corp (BRKR) Stock Price & Analysis
Bruker Corp (BRKR) fell 1.53% to USD 58.5 as of September 8, 2026 at 06:23 UTC, according to Nexqual real-time market data.
BRKR last closed at USD 58.5; the session ranged USD 58.26–59.78 on volume of 1,334,184 shares. Market capitalization is —, with a 52-week range of USD 30.09–65.3 (NMS). Source: Nexqual, September 8, 2026 at 06:23 UTC.
Key Statistics (as of September 8, 2026 at 06:23 UTC)
| Price | USD 58.5 |
|---|---|
| Change | ▼ 1.53% (down) |
| Previous Close | USD 58.5 |
| Open | USD 58.5 |
| Day Range | USD 58.26 – 59.78 |
| 52-Week Range | USD 30.09 – 65.3 |
| Volume | 1,334,184 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (BRKR)
Nexqual's technical model rates BRKR "BUY" based on 4 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 06:23 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 49.8 (neutral) |
| vs SMA50 | Below (USD 58.74) |
| MACD | 0.09 (positive) |
From Bruker Corp's Latest SEC 10-K Filing (filed 2026-02-27)
Key Strengths & Strategy (as disclosed to the SEC)
- For example, we are required to comply with the FDA's Quality System Regulation, which sets forth the good manufacturing requirements for medical devices.
- Our technology platforms include magnetic resonance, mass spectrometry, gas and liquid chromatography, X-ray, microscopy, metrology, and molecular spectroscopy technologies.
- This level of investment in research and development has historically exceeded the industry average and reflects our commitment to scientific research and technological advancement to provide innovative products and solutions to our customers and maintain our competitive advantage.
Partnerships
- BEST has an ongoing collaboration and a joint technology development agreement with Allegheny Technologies Incorporated to advance state-of-the-art niobium-based superconductors, including those used in MRI magnets for the medical industry, and preclinical MRI magnets used in the life-science tools industry.
- Our research and development efforts are conducted for the relevant products within each of the operating segments, as well as in collaboration with others on areas such as microfluidics, automation and workflow management software.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIO | Bio-Rad Laboratories, Inc. | USD 386.11 | ▼ 0.62% |
| CRL | Charles River Laboratories Inte | USD 288.5 | ▼ 1.12% |
| ICLR | ICON plc | USD 164.85 | ▲ 3.13% |
| WAT | Waters Corporation | USD 409.38 | ▼ 0.68% |
| MTD | Mettler-Toledo International, I | USD 1,345.26 | ▼ 1.64% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:23 UTC. This page is informational and not investment advice.